These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25963450)

  • 1. Anaphylaxis and serum sickness in patients receiving omalizumab: reviewing the data in light of clinical experience.
    Harrison RG; MacRae M; Karsh J; Santucci S; Yang WH
    Ann Allergy Asthma Immunol; 2015 Jul; 115(1):77-8. PubMed ID: 25963450
    [No Abstract]   [Full Text] [Related]  

  • 2. The unusual suspects: a surprise regarding reactions to omalizumab.
    Lieberman P
    Allergy Asthma Proc; 2007; 28(3):259-61. PubMed ID: 17619552
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of an anaphylactoid reaction to omalizumab.
    Dreyfus DH; Randolph CC
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):624-7. PubMed ID: 16680936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report.
    Cox L; Lieberman P; Wallace D; Simons FE; Finegold I; Platts-Mills T; Schwartz L
    J Allergy Clin Immunol; 2011 Jul; 128(1):210-2. PubMed ID: 21531014
    [No Abstract]   [Full Text] [Related]  

  • 5. Omalizumab and hypersensitivity reactions.
    Shankar T; Petrov AA
    Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):19-24. PubMed ID: 23242113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug hypersensitivity reactions: from clinical manifestations to an allergologic diagnosis.
    Bach S; Bircher AJ
    Eur Ann Allergy Clin Immunol; 2005 Jun; 37(6):213-8. PubMed ID: 16156399
    [No Abstract]   [Full Text] [Related]  

  • 7. [Omalizumab therapy in adolescents with severe allergic asthma - results of a post-marketing surveillance].
    Klyucheva M; von Berg A; Gappa M; Suerbaum C; Berdel D
    Pneumologie; 2013 Apr; 67(4):233-7. PubMed ID: 23576201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penicillin reactions among patients in venereal disease clinics. A national survey.
    Rudolph AH; Price EV
    JAMA; 1973 Jan; 223(5):499-501. PubMed ID: 4739133
    [No Abstract]   [Full Text] [Related]  

  • 9. Omalizumab: anaphylactic shock: sometimes occurs more than one hour after the injection.
    Prescrire Int; 2008 Feb; 17(93):22. PubMed ID: 18386396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab 75 mg. Whatever the dosage, the drug should be avoided in severe persistent asthma.
    Prescrire Int; 2011 Nov; 20(121):262. PubMed ID: 22066310
    [No Abstract]   [Full Text] [Related]  

  • 11. Omalizumab-associated anaphylactic reactions reported between January 2007 and June 2008.
    Lin RY; Rodriguez-Baez G; Bhargave GA
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):442-5. PubMed ID: 19927545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unpredicted adverse reaction to omalizumab.
    Jandus P; Hausmann O; Haeberli G; Gentinetta T; Mueller U; Helbling A
    J Investig Allergol Clin Immunol; 2011; 21(7):563-6. PubMed ID: 22312942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombocytopenia due to omalizumab].
    Lopez-Rodriguez JA; Santos Franco L
    An Pediatr (Barc); 2014 Jun; 80(6):413-4. PubMed ID: 24246236
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS; Souza-Machado A; Andradre-Lima M; Ferreira F; Honda A; Matozo TM;
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Churg-Strauss syndrome in a patient treated with omalizumab.
    Cisneros C; Segrelles G; Herráez L; Gonzalez A; Girón R
    J Investig Allergol Clin Immunol; 2013; 23(7):515-6. PubMed ID: 24654320
    [No Abstract]   [Full Text] [Related]  

  • 16. Omalizumab therapy in severe asthma: experience from the Spanish registry--some new approaches.
    Vennera Mdel C; Pérez De Llano L; Bardagí S; Ausin P; Sanjuas C; González H; Gullón JA; Martínez-Moragón E; Carretero JA; Vera E; Medina JF; Alvarez FJ; Entrenas LM; Padilla A; Irigaray R; Picado C;
    J Asthma; 2012 May; 49(4):416-22. PubMed ID: 22443408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids: out of fashion?
    Prescrire Int; 2015 Jun; 24(161):144. PubMed ID: 26436160
    [No Abstract]   [Full Text] [Related]  

  • 18. Is low-molecular weight iron dextran really the most risky iron?--Unconvincing data from an unconvincing study.
    DeLoughery TG; Auerbach M
    Am J Hematol; 2016 May; 91(5):451-2. PubMed ID: 26873795
    [No Abstract]   [Full Text] [Related]  

  • 19. Drugs to avoid during pregnancy: omalizumab and montelukast, too many uncertainties.
    Prescrire Int; 2014 Feb; 23(146):51. PubMed ID: 24669391
    [No Abstract]   [Full Text] [Related]  

  • 20. [Penicillin allergy].
    Young E
    Ned Tijdschr Geneeskd; 1985 Sep; 129(36):1713-6. PubMed ID: 4058600
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.